Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
22 studies found for:    s1304
Show Display Options
Rank Status Study
1 Recruiting S1304, Testing Two Doses of Carfilzomib With Dexamethasone for Relapsed or Refractory Myeloma
Condition: Relapsed or Refractory Multiple Myeloma
Interventions: Drug: dexamethasone;   Drug: carfilzomib
2 Recruiting Assess Biomarkers of Tobacco Exposure and Nicotine Pharmacokinetics in Smokers After a 5-Day In-Clinic Confinement Switch to an Electronic Cigarette or Nicotine Gum
Condition: Smoking
Interventions: Other: Usual Brand (UB) Cigarettes;   Other: Electronic Cigarette #1;   Other: Electronic Cigarette #2;   Other: Leading U.S. Nicotine Gum
3 Completed
Has Results
Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma
Condition: Asthma
Interventions: Drug: Omalizumab;   Drug: Placebo;   Drug: Fluticasone
4 Active, not recruiting MyNewOptions: An Online Study of Reproductive Life Planning and Contraceptive Action Planning
Conditions: Contraceptive Use;   Unintended Pregnancy
Interventions: Behavioral: Reproductive Life Planning (RLP);   Behavioral: Contraceptive Action Planning;   Behavioral: Contraception information
5 Recruiting Topiramate in Adolescents With Severe Obesity
Conditions: Obesity, Morbid;   Obesity;   Weight Loss
Interventions: Drug: Topiramate;   Other: Placebo
6 Recruiting Comparative Effectiveness of Antibiotics for Respiratory Infections
Conditions: Acute Otitis Media;   Acute Sinusitis;   Group A Streptococcal Pharyngitis
Interventions: Drug: Broad-spectrum antibiotics AOM:;   Drug: Broad spectrum antibiotics acute sinusitis;   Drug: Broad spectrum antibiotics GAS pharyngitis;   Drug: Narrow spectrum antibiotics AOM;   Drug: Narrow spectrum antibiotics GAS pharyngitis;   Drug: Narrow spectrum antibiotics acute sinusitis
7 Completed ACT-128800 in Relapsing-remitting Multiple Sclerosis
Condition: Relapsing-remitting Multiple Sclerosis
Interventions: Drug: ACT-128800;   Drug: Placebo
8 Terminated TF (SENSIMED Triggerfish) in Intraocular Anti-VEGF (Vascular Endothelial Growth Factor) Injection
Conditions: Neovascular Age Related Macular Degeneration (AMD);   Open Angle Glaucoma
Interventions: Procedure: Intraocular anti-VEGF injection;   Device: SENSIMED Triggerfish
9 Active, not recruiting Surveillance Imaging Modalities for Breast Cancer Assessment
Condition: Breast Cancer
Intervention:
10 Not yet recruiting Improving Transitional Care Experiences in Mental Health
Condition: Standard Treatment Versus Engagement Focused Treatment
Interventions: Behavioral: Engagement focused care;   Behavioral: Standard Care
11 Recruiting Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Conditions: Stage IB Breast Cancer;   Stage II Breast Cancer
Interventions: Radiation: regional nodal XRT;   Radiation: chestwall XRT;   Radiation: WBI
12 Completed
Has Results
Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
13 Recruiting Cervical Spondylotic Myelopathy Surgical Trial
Condition: Cervical Spondylosis With Myelopathy
Interventions: Procedure: Ventral (Front) decompression with Fusion;   Procedure: Dorsal (Back) Decompression with Fusion;   Procedure: Dorsal (back) Laminoplasty
14 Completed
Has Results
Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium;   Drug: placebo
15 Recruiting A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Condition: Asthma
Interventions: Drug: Mometasone Furoate/Formoterol MDI 100/5 mcg;   Drug: Mometasone Furoate/Formoterol MDI 200/5 mcg;   Drug: Mometasone Furoate MDI 100 mcg;   Drug: Mometasone Furoate MDI 200 mcg;   Drug: Albuterol 90 mcg /salbutamol 100 mcg HFA MDI;   Drug: Prednisone/prednisolone
16 Recruiting Evaluation of the Efficacy of High Throughput Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: AZD2014;   Drug: AZD4547;   Drug: AZD5363;   Drug: AZD8931;   Drug: Selumetinib;   Drug: Vandetanib;   Drug: Bicalutamide;   Drug: Olaparib;   Drug: Anthracyclines;   Drug: Taxanes;   Drug: cyclophosphamide;   Drug: DNA intercalators;   Drug: Methotrexate;   Drug: vinca alkaloids;   Drug: Platinum based chemotherapies;   Drug: Bevacizumab;   Drug: Mitomycine C;   Drug: Eribuline
17 Active, not recruiting A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain
Condition: Endometriosis
Interventions: Drug: ASP1707;   Drug: Placebo;   Drug: Leuprorelin acetate
18 Recruiting Exercise for Depressed Smokers
Conditions: Tobacco Smoking;   Smoking Cessation
Interventions: Behavioral: Aerobic Exercise;   Behavioral: Health Education
19 Recruiting Balancing Treatment Outcomes and Medication Burden Among Patients With Symptomatic Diabetic Peripheral Neuropathy
Condition: Diabetic Peripheral Neuropathy
Intervention: Behavioral: IVR Intervention Group
20 Enrolling by invitation Improving Quality of Life in Nursing Home Residents: A Cluster Randomized Clinical Trial of Efficacy
Condition: Quality of Life
Interventions: Behavioral: Communication;   Behavioral: Systematic Pain Assessment and Treatment;   Behavioral: Medication Review;   Behavioral: Occupational therapy;   Behavioral: Safety

   Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results    Last Page
Indicates status has not been verified in more than two years